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Ventricular septal defect (VSD) is a severe complication of acute myocardial infarction and has a high
mortality rate. This complication appears to have declined in the reperfusion era. It has mostly been reported
in elderly or female patients who suffer from anterior wall infarction, patients with multivessel coronary
artery disease (CAD) or occluded infarct-related artery (IRA) without collateral circulation, or patients
who have had delayed reperfusion therapy. Here, we report the case of a 60-year-old male patient who
presented with persistent chest pain and Killip I ST-segment-elevation myocardial infarction. Thrombolytic
therapy was started 3 hours after the onset of chest pain. Based on the subsidence of chest pain, resolution
of the elevated ST segment, and early peak of cardiac enzymes, reperfusion was thought to be successful.
However, on the third day of admission, the patient complained of dyspnea after defecation and was
found to have new-onset grade 3 pansystolic murmur over the left sternal border. Cardiac echography
showed an apical VSD. A Swan-Ganz catheter was inserted into the right side of the heart; analysis
of blood oxygen saturation revealed a 6% step-up of oxygen in the right ventricle. Coronary angiography
showed only one-vessel CAD and TIMI 3 flow in the IRA. The patient received intensive medical
management and underwent VSD repair and internal mammary artery bypass grafting to the left anterior
descending artery. His recovery was uneventful. This case illustrates that VSD can be found in patients
receiving early successful reperfusion therapy, with one-vessel CAD, and TIMI 3 flow in the IRA.
Key Words: acute myocardial infarction, ventricular septal defect, thrombolytic therapy
(Kaohsiung J Med Sci 2004;20:235–9)
Received: December 24, 2003    Accepted: March 1, 2004
Address correspondence and reprint requests to: Dr. Tsung-Hsien
Lin, Division of Cardiology, Department of Internal Medicine,
Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung
807, Taiwan.
E-mail: lth@kmu.edu.tw
© 2004 Elsevier. All rights reserved.
Ventricular septal defect (VSD) is a severe complication of
acute myocardial infarction (AMI). In the prethrombolytic
era, the reported incidence of this complication was about
1% to 2% [1,2]. VSD typically occurs during the first week
after infarction, with a mean time from symptom onset of 3
to 5 days [1,3,4]. Previous investigations have found that
being older, female, or a non-smoker are risk factors for its
development [5,6]; other studies have found that such
patients have also had no prior angina or myocardial
infarction (MI) [1,7,8]. VSD, a mechanical complication, is
generally associated with an occluded infarct-related artery
(IRA) and absence of collateral circulation [9,10]. Here, we
report a case of VSD complicating AMI in a patient who had
earlier undergone successful thrombolytic therapy.
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CASE PRESENTATION
A 60-year-old male patient complaining of persistent chest
pain was sent to our emergency room 2 hours after onset
of the pain. Physical examination and a 12-lead electro-
cardiogram were consistent with Killip I anterior wall ST-
elevation AMI (Figure 1). One hour later, and 3 hours after
the onset of pain, the patient underwent thrombolytic
therapy. Successful reperfusion was confirmed by chest
pain relief, resolution of ST elevation, and early peak car-
diac enzymes (7 hours after onset of pain). At admission,
the patient underwent echocardiography that showed
only mild mitral and tricuspid valve regurgitation and
good left ventricular systolic function.
On the third day of admission, however, the patient
complained of dyspnea after defecation. Physical exami-
nation showed new onset of a grade 3 pansystolic mur-
mur over the left sternal border. The patient underwent re-
peated echocardiography, which showed a 17 mm apical
VSD (Figure 2). Swan-Ganz catheterization showed a 6%
oxygen step-up in the right ventricle, giving a pulmonary:
systemic flow ratio of 2.73:1. The systolic pulmonary artery
pressure (SPAP) was 54 mmHg, and the mean pulmonary
capillary wedge pressure (PCWP) was 32 mmHg. The patient
underwent coronary angiography, which showed one-vessel
coronary artery disease (CAD) with 70% stenosis over the
proximal left anterior descending artery with TIMI 3 flow
(Figure 3). The patient was prescribed intravenous nitrogly-
cerin and a diuretic for markedly elevated PCWP. After 10
days of intensive medical care, he underwent VSD repair
and internal mammary artery bypass grafting to the left
anterior descending artery. His recovery was uneventful.
DISCUSSION
In the prethrombolytic era, the incidence of VSD with AMI
was about 1% to 2% [1,2]. Among the 41,021 patients in the
Global Utilization of Streptokinase and Tissue Plasminogen
Activator for Occluded Coronary Arteries (GUSTO-1) trials,
84 (0.2%) were confirmed to have VSD [11]. Thus, reperfusion
therapy might decrease the incidence of VSD.
The mean time from MI symptom onset to the devel-
opment of VSD was 1 day in GUSTO-1, a much shorter time
than the 3 to 5 days reported in the prethrombolytic era
[1,3,4]. This difference may be due to different pathophy-
siologic mechanisms. Thrombolytic therapy may prevent
Figure 1. Electrocardiogram showing ST-segment elevation and a
hyperacute T-wave at leads V1–V5 with reciprocal ST-segment depression
at leads II, III and aVF.
Figure 2. Echocardiography shows a 17 mm apical ventricular septal
defect with left to right shunt (arrow).
Figure 3. Left coronary angiogram: 30° right anterior oblique with 20°
caudal angulation shows 70% stenosis over the proximal left anterior
descending artery with TIMI 3 flow (arrow).
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extensive transmural necrosis, a prerequisite for cardiac
rupture in the prethrombolytic era. However, thrombolysis
may also cause myocardial hemorrhage during the “ly-
tic state”, thus facilitating the development of VSD. In
our case, the time from infarction to development of VSD
was 3 days, which was longer than that reported from
GUSTO-1. The relatively late onset VSD in our case implies
that, in addition to the myocardial hemorrhage associated
with thrombolytic therapy, other mechanisms, such as the
Valsalva maneuver elicited during defecation, may also be
responsible for the genesis of VSD in AMI. Therefore,
avoidance of constipation may protect against this serious
complication.
In patients undergoing thrombolysis, advanced age,
female sex, the absence of smoking, and thrombolytic
therapy more than 6 hours after symptom onset are often
associated with an increased risk of septal rupture [11].
VSD has also been associated with an occluded IRA with
minimal collaterals [9,10]. However, our case was not found
to have any of these variables, suggesting that septal rup-
ture may occur even in patients who have undergone ear-
lier thrombolysis and who have one-vessel CAD with TIMI
3 flow in the IRA.
VSD size and hemodynamic conditions have been
reported to significantly influence mortality. Cerin et al
demonstrated that cardiogenic shock, high SPAP, and
large surgical VSD diameter were more frequent in non-
surviving VSD patients [12]. In their study, mean pre-
operative SPAP was 56 mmHg and mean surgical VSD
diameter was 28 mm in non-surviving patients. In our
case, the SPAP was 54 mmHg and the VSD diameter by
echocardiography was 17 mm, both less than that in the
non-surviving group reported by Cerin et al. In addition,
there was no cardiogenic shock in our patient. These
findings perhaps render the prognosis for our patient more
favorable than that of patients in Cerin et al’s series.
The optimal timing of surgery and the most appropriate
approach to VSD patients have not been established [13,14].
It was long believed that the myocardium is too fragile to
repair shortly after an AMI. A waiting period of several
weeks before surgery was encouraged to allow the mar-
gin of the infarcted muscle to develop a firm scar for sur-
gical repair [15]. However, many patients have died while
awaiting surgery or undergoing emergency surgery after
sudden ventricular decompensation [16,17]. Therefore, it
might be advisable to follow the suggestions of Cerin et al,
who stated that an attempt should be made to stabilize
patients in the intensive care unit with aggressive medical
therapy and intra-aortic balloon pumping before surgery.
If this is not feasible, surgery must be performed immediate-
ly [12]. As our patient had good heart function, no cardioge-
nic shock, one-vessel CAD with TIMI 3 flow in the IRA,
and only mild congestive heart failure, he was first given
intensive medical treatment to allow the infarcted muscle
time to heal. After 10 days of intensive medical care, when
he was in a generally stable condition, he received surgical
management. Concomitant ventricular reconstruction and
revascularization were uneventful.
In conclusion, although VSD is mostly found in patients
with multivessel CAD, delayed reperfusion therapy, and an
occluded IRA without collateral circulation, this complica-
tion can also occur in patients receiving early successful
reperfusion therapy with one-vessel CAD and TIMI 3
flow in the IRA. A detailed physical examination, early rap-
id echocardiography diagnosis, aggressive medical man-
agement, and surgical intervention are required to opti-
mize recovery and survival.
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